Status:

COMPLETED

Performance of an Investigational Blood Glucose Monitoring System

Lead Sponsor:

Ascensia Diabetes Care

Conditions:

Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study was to demonstrate that untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.

Eligibility Criteria

Inclusion

  • Males and females, 18 years of age or older.
  • People with type 1 or type 2 diabetes.
  • Able to speak, read and understand English.
  • Willing to complete all study procedures.

Exclusion

  • Hemophilia or any other bleeding disorder.
  • Pregnancy.
  • Physical, visual or neurological impairments that would make the person unable to perform testing with the BGM.
  • Previously participated in a blood glucose monitoring study using the Ninja 3 Plus BGMS.
  • Working for a medical laboratory, hospital or other clinical setting that involves training on or clinical use of blood glucose meters.
  • Working for a competitive medical device company, or having an immediate family member who works for such a company.
  • A condition, which in the opinion of the investigator or designee, would put the person or study conduct at risk.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2013

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT01824355

Start Date

March 1 2013

End Date

March 1 2013

Last Update

February 29 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Consumer Product Testing Co.

Fairfield, New Jersey, United States, 07004